Price data is not available
INNOVENT BIOLGCS UNSP/ADR by Innovent Biologics Inc.
IVBIYOTCPK
INNOVENT BIOLGCS UNSP/ADR by Innovent Biologics rose 3.8% from $41.98 to $43.55, behind the S&P 500's +10.6%. Its worst day was Oct 20 (−17.6%), and its low came Jun 18 at $39.25.
Dec 15, 2025 – Nov 5, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
INNOVENT BIOLGCS UNSP/ADR by Innovent Biologics closed at its lowest level of the year, 6.5% below where the year started.
−6.5% · S&P 500 +1.0%
INNOVENT BIOLGCS UNSP/ADR by Innovent Biologics closed at its highest level of the year, 29.3% above where the year started.
Story events cover the past 12 months · Times ET
+10.1% · S&P 500 +0.4%
INNOVENT BIOLGCS UNSP/ADR by Innovent Biologics shares fell 17.6%, while the S&P 500 rose 0.3%.
−17.6%, the year's worst day · S&P 500 +0.3%
Where it ended: a close of $43.55 on Nov 5, 2026.
Nothing in the past 12 months.
All IVBIY earningsNothing in the past 12 months.
All IVBIY analyst actionsNothing in the past 12 months.
All IVBIY dividend historyNothing in the past 12 months.
All IVBIY news
